000 | 00971 a2200277 4500 | ||
---|---|---|---|
005 | 20250517203653.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.24078 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKulemzin, Sergey V | |
245 | 0 | 0 |
_aVEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells. _h[electronic resource] |
260 |
_bOncotarget _cFeb 2018 |
||
300 |
_a9021-9029 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aGorchakov, Andrey A | |
700 | 1 | _aChikaev, Anton N | |
700 | 1 | _aKuznetsova, Valeriya V | |
700 | 1 | _aVolkova, Olga Y | |
700 | 1 | _aMatvienko, Daria A | |
700 | 1 | _aPetukhov, Alexey V | |
700 | 1 | _aZaritskey, Andrey Y | |
700 | 1 | _aTaranin, Alexandr V | |
773 | 0 |
_tOncotarget _gvol. 9 _gno. 10 _gp. 9021-9029 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.24078 _zAvailable from publisher's website |
999 |
_c28148317 _d28148317 |